Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-8 of 8 for NMO

Edit search filters
  1. An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

    Rochester, MN

  2. A Double Blind Trial to Evaluate the Safety and Efficacy of Eculizumab in Relapsing NMO Patients (PREVENT Study)

    Rochester, MN

  3. A Study to Extend a Previous Trial of Eculizumab in Patients with Relapsing Neuromyelitis Optica

    Scottsdale/Phoenix, AZ

  4. A Study to Evaluate the Safety And Effectiveness of Using Eculizumab in Patients with Relapsing Neuromyelitis Optica

    Scottsdale/Phoenix, AZ

  5. A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders

    Rochester, MN

  6. A Study to Evaluate the Effectiveness and Safety of Ravulizumab in Adult Participants with Neuromyelitis Optica Spectrum Disorder

    Rochester, MN

  7. Maintenance Plasma Exchange for Neuromyelitis Optica

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Neuromyelitis Optica Clinical Consortium (NMOCC) Clinical Database Development for Neuromyelitis Optica Spectrum Disorders

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer